Structure-based library design: Molecular modelling merges with combinatorial chemistry

Current Opinion in Chemical Biology

Volumn 4, Issue 3, 2000, Pages 283-286

  Böhm, Hans Joachim ^a   Stahl, Martin ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

COMPUTER AIDED DESIGN; ENZYME CHEMISTRY; GENE LIBRARY; MOLECULAR MODEL; PROTEIN STRUCTURE; REVIEW;

EID: 0038259177     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00090-9     Document Type: Review

References (49)

1. Kubinyi H. Structure-based design of enzyme inhibitors and receptor ligands. Curr Opin Drug Disc Dev. 1:1998;4-15.
2. Babine R.E., Bender S.L. Molecular recognition of protein-ligand complexes: applications to drug design. Chem Rev. 97:1997;1359-1472.
3. Hubbard R.E. Can drugs be designed? Curr Opin Biotechnol. 8:1997;696-700.
4. Bohacek R.S., McMartin C., Guida W.C. The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev. 16:1996;3-50.
5. Murcko M.A., Caron P.R., Charifson P.S. Structure-based drug design. Annu Rep Med Chem. 34:1999;297-306.
6. Gund P., Sigal N.H. Applying informatics systems to high-throughput screening and analysis. PharmaInformatics. 1999;S25-S29.
7. Spencer R.W. High-throughput screening of historic collections: observations on file size, biological targets and file diversity. Biotechnol Bioeng. 61:1998;61-67.
8. Oldenburg K.R. Current and future trends in high throughput screening for drug discovery. Annu Rep Med Chem. 33:1998;301-311.
9. Böhm H.J., Banner D.W., Weber L. Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors. J Comput Aided Mol Des. 13:1999;51-56.
10. Sun Y., Ewing T.J.A., Skillman A.G., Kuntz I.D. CombiDOCK: structure-based combinatorial docking and library design. J Comput Aided Mol Des. 12:1998;579-604.
11. Kick E.K., Roe D.C., Skillman A.G., Liu G., Ewing T.J.A., Sun Y., Kuntz I.D., Ellman J.A. Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem Biol. 4:1997;297-307.
12. Murray C.W., Clark D.E., Auton T.R., Firth M.A., Li J., Sykes R.A., Waskowycz B., Westhead D.R., Young S.C. PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology. J Comput Aided Mol Des. 11:1996;193-207.
13. Dixon S.J. Evaluation of CASP2 docking section. Proteins. S1:1997;198-204.
14. Kramer B., Rarey M., Lengauer T. Evaluation of the FlexX incremental construction algorithm for protein-ligand docking. Proteins. 37:1999;228-241.
15. Jones G., Willet P., Glen R.C., Leach A.R., Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 267:1997;727-748.
16. Gilson M.K., Given J.A., Head M.S. A new class of models for computing receptor-ligand binding affinities. Chem Biol. 4:1997;87-92.
17. Hirst J.D. Predicting ligand-binding energies. Curr Opin Drug Disc Dev. 1:1998;28-33.
18. Tame J.R.H. Scoring functions: a view from the bench. J Comput Aided Mol Des. 13:1999;99-108. A careful and clear analysis of the shortcomings of current scoring functions.
19. Knegtel R.M.A., Grootenhuis P.D.J. Binding affinities and non-bonded interaction energies. Kubinyi H., Folkers G., McMartin Y.C. 3D QSAR in Drug Design: Ligand Protein Interactions and Molecular Similarity. 1998;99-114 Kluwer/Escom, Dordrecht, The Netherlands.
20. Oprea T.I., Marshall G.R. Receptor-based prediction of binding activities. Kubinyi H., Folkers G., McMartin Y.C. 3D QSAR in Drug Design: Ligand Protein Interactions and Molecular Similarity. 1998;3-17 Kluwer/Escom, Dordrecht, The Netherlands.
21. Davies T.G., Hubbard R.E., Tame J.R.H. Relating structure to thermodynamics: the crystal structures and binding affinity of eight OppA-peptide complexes. Protein Sci. 8:1999;1432-1444.
22. So S.S., Karplus M.A. Comparative study of ligand-receptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors. J Comput Aided Mol Des. 13:1999;243-258.
23. Shoichet B.K., Leach A.R., Kuntz I.D. Ligand solvation in molecular docking. Proteins. 34:1999;4-16. Highlights problems that can occur when standard force fields are used as scoring functions and points to a possible solution.
24. Vieth M., Hirst J.D., Kolinski A., Brooks C.L. Assessing energy functions for flexible docking. J Comput Chem. 19:1998;1612-1622.
25. Murray C.W., Auton T.R., Elridge M.D. Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the method. J Comput Aided Mol Des. 12:1999;503-519.
26. Wang R., Liu L., Lai L., Tang Y. SCORE: a new empirical method for estimating the binding affinity of a protein-ligand complex. J Mol Model. 4:1998;379-394.
27. Böhm H.J. Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J Comput Aided Mol Des. 12:1998;309-323.
28. Gehlhaar D.K., Verkhivker G.M., Rejto P.A., Sherman C.J., Fogel D.B., Freer S.T. Molecular recognition of the inhibitor AG- by HIV-1 protease-conformationally flexible docking by evolutionary programming. Chem Biol. 1343:1995;2. 317-324.
29. Mitchell J.B.O., Laskowski R.A., Alex A., Forster M.J., Thornton J.M. BLEEP - a potential of mean force describing protein-ligand interactions. II. Calculation of binding energies and comparison with experimental data. J Comput Chem. 20:1999;1177-1185. A new and interesting knowledge-based scoring function is described.
30. Muegge I., Martin Y.C., Hajduk P.J., Fesik S.W. Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein. J Med Chem. 42:1999;2498-2503.
31. Muegge I., Martin Y.C. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem. 42:1999;791-804. A promising new knowledge-based scoring function is described.
32. Ewing T.J.A., Kuntz I.D. Critical evaluation of search algorithms for automated molecular docking and database screening. J Comput Chem. 18:1997;1175-1189.
33. Charifson P.S., Corkery J.J., Murcko M.A., Walters W.P. Consensus scoring: a method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem. 42:1999;5100-5109. An important paper on the comparison of current scoring functions in virtual screening applications.
34. Stahl M., Böhm H.J. Development of filter functions for protein-ligand docking. J Mol Graph Model. 16:1998;121-132.
35. Knegtel R.M.A., Wagener M. Efficacy and selectivity in flexible database docking. Proteins. 37:1999;334-345.
36. Makino S., Ewing T.J.A., Kuntz I.D. DREAM++: flexible docking program for virtual combinatorial libraries. J Comput Aided Mol Des. 13:1999;513-532.
37. Kirkpatrick D.L., Watson S., Ulhaq S. Structure-based drug design: combinatorial chemistry and molecular modeling. Comb Chem High Throughput Screen. 2:1999;211-221.
38. Kick E.K., Roe D.C., Skillman A.G., Liu G., Ewing T.J., Sun Y., Kuntz I.D., Ellman J.A. Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem Biol. 4:1997;297-307.
39. Haque T.S., Skillman A.G., Lee C.E., Habashita H., Gluzman I.Y., Ewing T.J., Goldberg D.E., Kuntz I.D., Ellman J.A. Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II. J Med Chem. 42:1999;1428-1440. A recent paper from the Ellman and Kuntz group describing a successful application of combinatorial docking.
40. Lew A., Chamberlin A.R. Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistry. Bioorg Med Chem Lett. 9:1999;3267-3272.
41. Minke W.E., Hong F., Verlinde C.L., Hol W.G., Fan E. Using a galactose library for exploration of a novel hydrophobic pocket in the receptor binding site of the Escherichia coli heat-labile enterotoxin. J Biol Chem. 274:1999;33469-33473.
42. Böhm H.J. The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des. 6:1992;61-78.
43. Fink B.E., Mortensen D.S., Stauffer S.R., Zachary D.A., Katzenellenbogen J.A. Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens. Chem Biol. 6:1999;205-219.
44. Spellmeyer D.C., Grootenhuis P.D.J. Recent developments in molecular diversity: computational apporaches to combinatorial chemistry. Ann Rep Med Chem. 34:1999;287-296.
45. Cramer R.D., Poss M.A., Hermsmeier M.A., Caulfield T.J., Kowala M.C., Valentine M.T. Prospective identification of biologically active structures by topomer shape similarity searching. J Med Chem. 42:1999;3919-3933.
46. Miller M.D., Sheridan R.P., Kearsley S.K. SQ: a program for rapidly producing pharmacophorically relevant molecular superpositions. J Med Chem. 42:1999;1505-1514.
47. Mason J.S., Morize I., Menard P.R., Cheney D.L., Hulme C., Labaudiniere R.F. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. J Med Chem. 42:1999;3251-3264.
48. Ajay Bemis G.W., Murcko M.A. Designing libraries with CNS activity. J Med Chem. 42:1999;4942-4951.
49. Walters W.P., Ajay Murcko M.A. Recognizing molecules with drug-like properties. Curr Opin Chem Biol. 3:1999;384-387.